Cierra N. Sharp

Cierra N. Sharp

Aug 16, 2016

Group 6 Copy 20
1
Please wait...

About This Project

A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

Blast off!

Browse Other Projects on Experiment

Related Projects

A fossil leaf site west of Ellensburg: part of the Ellensburg Flora? Or its own thing?

An ash-laden fossil leaf deposit in Central Washington assigned to the Ellensburg Flora (12 to 10 million years...

How has a Hemileuca moth evolved to live in a unique coastal Texas ecosystem?

We are studying a population of moths in an unique oak ecosystem in a coastal barrier island environment to...

Backer Badge Funded